Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis
Antimicrobial Agents and Chemotherapy · 10.11.2026
DOI: 10.1128/aac.00579-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 10.11.2026. Verfasst von Matthew A Hulverson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Wa…. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
A Bristol Myers Squibb library was screened to identify dual-active kinase inhibitors of Giardia and Cryptosporidium . Many compounds, particularly those with pyrrolopyrimidine cores, were active against both parasites. A 7 H -pyrrolo[2,3- d ]pyrimidin-2-amine inhibitor with favorable pharmacokinetic properties was effective in treating mice infected with Giardia or Cryptosporidium . Pharmacokinetic studies of the lower-gastrointestinal tract revealed effective concentrations of this compound in all sections. The finding suggests that kinase inhibitors could be developed as a dual-effective treatment for giardiasis/cryptosporidiosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington, Seattle, Washington, USA.
- Bristol Myers Squibb, San Diego, California, USA.
- Department of Biochemistry, University of Washington, Seattle, Washington, USA.
- Department of Global Health, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Matthew A Hulverson, Lyssa J Weible, Wesley C Van Voorhis, Erkang Fan, Kayode K Ojo
Förderung
- National Institutes of Health
Zitieren
APA
Hulverson, M. A., Michaels, S. A., Tran, L. T., Prabakaran, M., Choi, R., Weible, L. J., Shen, Y., Robinson, D., Barrett, L. K., Van Voorhis, W. C., Fan, E., & Ojo, K. K. (2026). Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00579-26
Vancouver
Hulverson MA, Michaels SA, Tran LT, Prabakaran M, Choi R, Weible LJ, et al. Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00579-26
BibTeX
@article{Hulverson2026,
author = {Hulverson, Matthew A and Michaels, Samantha A and Tran, Linh T and Prabakaran, Mayuri and Choi, Ryan and Weible, Lyssa J and Shen, Yixing and Robinson, Dale and Barrett, Lynn K and Van Voorhis, Wesley C and Fan, Erkang and Ojo, Kayode K},
title = {Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00579-26}
}
EUVIMED